Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Melanoma Research|November 10, 2020
Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic targetRiyue Bao, Oliver Surriga, Daniel J Olson, et al.
European Radiology Experimental|November 3, 2020
Differentiating combined pulmonary fibrosis and emphysema from pure emphysema: utility of late gadolinium-enhanced MRIHannah Fleming, Simon M Clifford, Aoife Haughey, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 5, 2022
Recommended first-line management of brain metastases from melanoma: A multicenter survey of clinical practicePaola Anna Jablonska, Chin Heng Fong, Timothy Kruser, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2003
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patientsF Stephen Hodi, Martin C Mihm, Robert J Soiffer, et al.
Frontiers in Oncology|June 6, 2019
Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical TrialsRamy Gadalla, Babak Noamani, Bethany L MacLeod, et al.
Obstetrics and Gynecology International|June 12, 2018
Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary PerspectiveYeh Chen Lee, Nazlin Jivraj, Catherine O'Brien, et al.
BMJ Open|June 17, 2017
In patients with severe uncontrolled asthma, does knowledge of adherence and inhaler technique using electronic monitoring improve clinical decision making? A protocol for a randomised controlled trialMatshediso C Mokoka, Lorna Lombard, Elaine M MacHale, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patientsF Stephen Hodi, Marcus Butler, Darryl A Oble, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2019
Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohortNeil H Segal, Sai-Hong I Ou, Ani Balmanoukian, et al.
Investigational New Drugs|March 3, 2023
Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumorsAntonio Jimeno, Joaquina Baranda, Wade T Iams, et al.
Pageof 4